Correlation Between Monopar Therapeutics and ALLSTATE

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Monopar Therapeutics and ALLSTATE at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Monopar Therapeutics and ALLSTATE into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Monopar Therapeutics and ALLSTATE P 535, you can compare the effects of market volatilities on Monopar Therapeutics and ALLSTATE and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Monopar Therapeutics with a short position of ALLSTATE. Check out your portfolio center. Please also check ongoing floating volatility patterns of Monopar Therapeutics and ALLSTATE.

Diversification Opportunities for Monopar Therapeutics and ALLSTATE

-0.37
  Correlation Coefficient

Very good diversification

The 3 months correlation between Monopar and ALLSTATE is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding Monopar Therapeutics and ALLSTATE P 535 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ALLSTATE P 535 and Monopar Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Monopar Therapeutics are associated (or correlated) with ALLSTATE. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ALLSTATE P 535 has no effect on the direction of Monopar Therapeutics i.e., Monopar Therapeutics and ALLSTATE go up and down completely randomly.

Pair Corralation between Monopar Therapeutics and ALLSTATE

Given the investment horizon of 90 days Monopar Therapeutics is expected to generate 18.37 times more return on investment than ALLSTATE. However, Monopar Therapeutics is 18.37 times more volatile than ALLSTATE P 535. It trades about 0.42 of its potential returns per unit of risk. ALLSTATE P 535 is currently generating about 0.11 per unit of risk. If you would invest  2,360  in Monopar Therapeutics on November 7, 2024 and sell it today you would earn a total of  2,440  from holding Monopar Therapeutics or generate 103.39% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy95.0%
ValuesDaily Returns

Monopar Therapeutics  vs.  ALLSTATE P 535

 Performance 
       Timeline  
Monopar Therapeutics 

Risk-Adjusted Performance

21 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Monopar Therapeutics are ranked lower than 21 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Monopar Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.
ALLSTATE P 535 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ALLSTATE P 535 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, ALLSTATE is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Monopar Therapeutics and ALLSTATE Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Monopar Therapeutics and ALLSTATE

The main advantage of trading using opposite Monopar Therapeutics and ALLSTATE positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Monopar Therapeutics position performs unexpectedly, ALLSTATE can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ALLSTATE will offset losses from the drop in ALLSTATE's long position.
The idea behind Monopar Therapeutics and ALLSTATE P 535 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Other Complementary Tools

Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Global Correlations
Find global opportunities by holding instruments from different markets
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios